• 1
    Des Jarlais D. C., McKnight C., Goldblatt C., Purchase D. Doing harm reduction better: syringe exchange in the United States. Addiction 2009; Epub ahead of print 10 February. DOI: 10.1111/j.1360-0443.2008.02465.x.
  • 2
    Grund J.-P. C., Blanken P., Adriaans N. F. P., Kaplan C. D., Barendregt C., Meeuwsen M. Reaching the unreached: targeting hidden IDU populations with clean needles via known users. J Psychoact Drugs 1992; 24: 417.
  • 3
    Heckathorn D. D. Respondent-driven sampling: a new approach to the study of hidden populations. Soc Probl 1997; 44: 17499.
  • 4
    Broadhead R. S., Heckathorn D. D., Weakliem D. L., Anthony D. L., Madray H., Mills R. J. et al. Harnessing peer networks as an instrument for AIDS prevention: results from a peer-driven intervention. Public Health Rep 1998; 113: 4257.
  • 5
    UNAIDS. HIV/AIDS and Human Rights: International Guidelines. Joint United Nations Programme on HIV/AIDS (UNAIDS), New York and Geneva. 2006.
  • 6
    UNAIDS. Handbook for legislators on HIV/AIDS, law and human rights. Joint United Nations Programme on HIV/AIDS (UNAIDS) & Inter Parliamentary Union (IPU), Geneva. 1999.
  • 7
    De P., Cox J., Boivin J. F., Platt R. W., Jolly A. M. Social network-related risk factors for bloodborne virus infections among injection drug users receiving syringes through secondary exchange. J Urban Health 2008; 85: 7789.
  • 8
    Tyndall M. W., Bruneau J., Brogly S., Spittal P., O'Shaughnessy M. V., Schechter M. T. Satellite needle distribution among injection drug users: policy and practice in two Canadian cities. J Acquir Immune Defic Syndr 2002; 31: 98105.
  • 9
    European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Overdose—a major cause of avoidable death among young people. Drugs in Focus 2005; 13: 14. Available at: (accessed 17 April 2009).
  • 10
    Sporer K. A., Kral A. H. Prescription naloxone: a novel approach to heroin overdose prevention. Ann Emerg Med 2007; 49: 1727.